Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.
2.

Frontotemporal White Matter in Adolescents with, and at-Risk for, Bipolar Disorder.

de Zwarte SM, Johnston JA, Cox Lippard ET, Blumberg HP.

J Clin Med. 2014 Mar 10;3(1):233-54. doi: 10.3390/jcm3010233. Review.

3.

Diffusion tensor imaging, structural connectivity, and schizophrenia.

Whitford TJ, Kubicki M, Shenton ME.

Schizophr Res Treatment. 2011;2011:709523. doi: 10.1155/2011/709523. Epub 2011 Jul 17.

4.

The Role of Astrocytes in Metabolism and Neurotoxicity of the Pyrrolizidine Alkaloid Monocrotaline, the Main Toxin of Crotalaria retusa.

Pitanga BP, Nascimento RP, Silva VD, Costa SL.

Front Pharmacol. 2012 Aug 3;3:144. doi: 10.3389/fphar.2012.00144. eCollection 2012.

5.

Family-based association study of early growth response gene 3 with child bipolar I disorder.

Gallitano AL, Tillman R, Dinu V, Geller B.

J Affect Disord. 2012 May;138(3):387-96. doi: 10.1016/j.jad.2012.01.011. Epub 2012 Feb 25.

6.

Prolactin-a biomarker for antipsychotic treatment response?

Agarwal SM, Rao NP, Jhamnani K, Venkatasubramanian G, Behere RV, Varambally S, Gangadhar BN.

Prim Care Companion CNS Disord. 2011;13(4). pii: PCC.11l01155. doi: 10.4088/PCC.11l01155. No abstract available.

7.

Neuregulin-1β for the treatment of systolic heart failure.

Sawyer DB, Caggiano A.

J Mol Cell Cardiol. 2011 Oct;51(4):501-5. doi: 10.1016/j.yjmcc.2011.06.016. Epub 2011 Jun 28. Review.

8.

Evidence for maternal-fetal genotype incompatibility as a risk factor for schizophrenia.

Palmer CG.

J Biomed Biotechnol. 2010;2010:576318. doi: 10.1155/2010/576318. Epub 2010 Apr 6. Review.

9.

Fibroblast growth factors in schizophrenia.

Terwisscha van Scheltinga AF, Bakker SC, Kahn RS.

Schizophr Bull. 2010 Nov;36(6):1157-66. doi: 10.1093/schbul/sbp033. Epub 2009 May 8. Review.

10.

Can we identify genes for alcohol consumption in samples ascertained for heterogeneous purposes?

Hansell NK, Agrawal A, Whitfield JB, Morley KI, Gordon SD, Lind PA, Pergadia ML, Montgomery GW, Madden PA, Todd RD, Heath AC, Martin NG.

Alcohol Clin Exp Res. 2009 Apr;33(4):729-39. doi: 10.1111/j.1530-0277.2008.00890.x. Epub 2009 Jan 22.

11.

The role of the medical librarian in the basic biological sciences: a case study in virology and evolution.

Tennant MR, Miyamoto MM.

J Med Libr Assoc. 2008 Oct;96(4):290-8. doi: 10.3163/1536-5050.96.4.004. No abstract available.

12.

Effect of Rhesus D incompatibility on schizophrenia depends on offspring sex.

Palmer CG, Mallery E, Turunen JA, Hsieh HJ, Peltonen L, Lonnqvist J, Woodward JA, Sinsheimer JS.

Schizophr Res. 2008 Sep;104(1-3):135-45. doi: 10.1016/j.schres.2008.06.022. Epub 2008 Aug 9.

13.

Association study in the 5q31-32 linkage region for schizophrenia using pooled DNA genotyping.

Zaharieva I, Georgieva L, Nikolov I, Kirov G, Owen MJ, O'Donovan MC, Toncheva D.

BMC Psychiatry. 2008 Feb 25;8:11. doi: 10.1186/1471-244X-8-11.

14.

Mice lacking the immediate early gene Egr3 respond to the anti-aggressive effects of clozapine yet are relatively resistant to its sedating effects.

Gallitano-Mendel A, Wozniak DF, Pehek EA, Milbrandt J.

Neuropsychopharmacology. 2008 May;33(6):1266-75. Epub 2007 Jul 18.

15.

Decreased mRNA expression of netrin-G1 and netrin-G2 in the temporal lobe in schizophrenia and bipolar disorder.

Eastwood SL, Harrison PJ.

Neuropsychopharmacology. 2008 Mar;33(4):933-45. Epub 2007 May 16.

16.

The schizophrenic faces of PICK1.

Dev KK, Henley JM.

Trends Pharmacol Sci. 2006 Nov;27(11):574-9. Epub 2006 Sep 29. Review.

17.

HLA-B maternal-fetal genotype matching increases risk of schizophrenia.

Palmer CG, Hsieh HJ, Reed EF, Lonnqvist J, Peltonen L, Woodward JA, Sinsheimer JS.

Am J Hum Genet. 2006 Oct;79(4):710-5. Epub 2006 Aug 15.

18.

Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia.

Georgieva L, Moskvina V, Peirce T, Norton N, Bray NJ, Jones L, Holmans P, Macgregor S, Zammit S, Wilkinson J, Williams H, Nikolov I, Williams N, Ivanov D, Davis KL, Haroutunian V, Buxbaum JD, Craddock N, Kirov G, Owen MJ, O'Donovan MC.

Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12469-74. Epub 2006 Aug 4.

19.

Intermediate phenotypes in schizophrenia: a selective review.

Preston GA, Weinberger DR.

Dialogues Clin Neurosci. 2005;7(2):165-79. Review.

20.

Theories of schizophrenia: a genetic-inflammatory-vascular synthesis.

Hanson DR, Gottesman II.

BMC Med Genet. 2005 Feb 11;6:7. Review.

Supplemental Content

Support Center